Application no. and date | 99968939.1 (espacenet) (Federated) (European Patent Register), 19991222 | Patent/reg. no. and date | DK/EP 1140181, 20041110 | Publication date | 20011010 | Priority no. and date | US 113786 P, 19981223, US 385214, 19990827 | EP pub. no. and date |
EP 1140181 20011010 | Effective date | | Applicant/owner | The Board of Regents of the University of Texas System, 201 West 7th Street
Austin,
Texas 78701, US, G.D. Searle LLC, 575 Maryville Centre Drive
St. Louis, Missouri 63141, US | Applicant ref. no. | 120688 | Inventor | MASFERRER, Jaime, L., 1213 Blairshire
Ballwin, MO 63011, US, MILAS, Luka, 2708 Quenby
Houston, TX 77005, US, MCKEARN, John, P., 18612 Babler Meadows Drive
Glencoe, MO 63038, US | Representative | Budde Schou A/S, Dronningens Tværgade 30, 1302 København K | Opponent | | IPC Class | A61K 31/415, A61P 35/00, A61K 41/00 | Title | Konbinationsterapi af bestråling og en COX-2-inhibitor til behandling af neoplasi | Int. application no. | US1999030669 | Int. publication no. | WO2000038716 | Related patent (certificate) | | Status | Bortfaldet | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|